Catalysts
PRODUCTS
-
The MPBR-0122CSP3 is a compact, high-performance MMIC power divider/power splitter that operates across the 1 to 22 GHz frequency range.
-
Gain access to Culture bioreactors when you need rapid overflow experimental capacity.
Benefits
Progress studies faster
Run overflow projects and conduct parallel experiments with Culture to reduce time and alleviate bottlenecks.
Stay agile in your capacity planning
Scale your workload at Culture according to your current needs. Respond rapidly to surging demands.
Eliminate your capital equipment spend
Leverage Culture’s facility quickly to avoid building out lab space, spending capital on equipment, and hiring specialized staff.
-
PHCbi brand’s LabSVIFT® IoT lab management solution is designed to provide real-time visibility and control of laboratory equipment and environments across single or multiple facilities. This cloud-based platform enables centralized monitoring, customizable alerts, and secure data access via a web-based dashboard. The new health check* function continuously evaluates equipment performance, identifies irregularities, and provides recommended corrective actions to maintain optimal operation. The system supports FDA 21 CFR Part 11 compliance and is compatible with select PHCbi and third-party devices. *health check function compatibility varies by model
-
The Exodus Advanced Communications AMP20184 is a solid-state, high-power amplifier designed for various applications, including EMI/RFI testing, laboratory use, CW/Pulse operations, and all communication needs.
-
For more than 20 years, Eurofins PSS Insourcing Solutions® has partnered with biotech and pharmaceutical companies to successfully validate and open new or remodeled facilities, meeting regulatory requirements. With a proven track record across numerous facility projects, our flexible, client-focused model ensures seamless integration with internal teams and third-party vendors, delivering high satisfaction and long-term partnerships.
WHITE PAPERS AND CASE STUDIES
-
A Proactive Approach To Service Line Inventory
In this case study, learn how Silver Creek Water Corporation successfully created a lead service line inventory with the help of 120Water. They have only 7 unknown service lines left out of 7,000 and plan to eliminate them through a resident survey.
-
How Waterloo Harnessed Qatium's Digital Platform
Read about the City of Waterloo, that needed an intuitive, low-cost tool to empower operators without requiring specialized technical expertise.
-
Fyfe - Drinking Water Reservoir Seismic Rehabilitation
Upgrading reservoirs for seismic resilience requires high-strength, lightweight solutions. Fiber-reinforced polymer wraps provide essential structural reinforcement without adding dead weight, allowing for flexible, cost-effective installation that ensures long-term utility safety and continued community use of recreational spaces.
-
Helping To Power The WHO Solidarity Trial Against COVID-19
To overcome the unprecedented challenges of large-scale global clinical trials, adopting data capture solutions is essential for ensuring the success of critical research initiatives.
-
Educating Globally Diverse Populations Through Branding & Visuals
See how this customized educational approach significantly enhanced recruitment and retention efforts, helping to ensure a more inclusive trial for Nonobstructive Hypertrophic Cardiomyopathy (nHCM).
-
Early-Stage Development In Rare Pediatric Oncology
Learn about the strategic approach a biotechnology company utilized to address significant hurdles in launching a Phase 1 clinical trial for a novel therapy targeting a rare pediatric cancer.
-
Scaling Global Vaccine Mega-Trials For A Top Five Pharma
See how high-volume enrollment, dynamic safety data capture, and rapid iteration can support global studies operating under intense timelines and scale.
-
Regulatory Affairs Project Manager
Discover how a ProPharma consultant effectively integrated tools, streamlined processes, and enhanced communications within a biotech company to ensure regulatory filings would be delivered promptly and with the highest level of quality.
-
A Comprehensive Solution For Critical Sample Analysis
Discover how Germfree Laboratories overcame challenges for the Royal Canadian Mounted Police by designing a mobile lab with advanced biocontainment and state-of-the-art communication systems.
-
Lead Identification And Optimization For Computational Drug Discovery
AI-generated Fab molecules promise speed, but can computational designs actually express and bind at scale? A high-throughput screening workflow offers a data-backed answer.
-
Medable's Japanese Clinical Trial Exceeds FPI Date And eCOA Adherence
A top-10 global pharma company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites in Japan. Explore an initiative to enhance the patient and site experience.
-
Addressing Site Selection Challenges In DMD Gene Therapy Studies
Effective site selection is critical for the success of DMD gene therapy trials. This study details innovative methodologies employed to streamline and improve site identification.
NEWS
-
PulpFixin Announces Strategic Distribution Partnership With Wildcat Laboratory Solutions To Expand Sustainable Lab Products Across The UK And EU4/14/2025
PulpFixin, an innovator of sustainable laboratory products, announced today a new distribution partnership with Wildcat Laboratory Solutions a leading provider of lab equipment and solutions across the United Kingdom and European Union.
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.
-
Dielectric Partners With Foccus Digital For Brazilian Broadcast Growth8/15/2025
Dielectric’s Brazilian presence is about to radiate stronger through a new partnership with Foccus Digital that expand Dielectric’s broadcast business throughout the country.
-
Enhanc3D Genomics Launches Suite Of 3D Multi-Omics Solutions To Accelerate Drug Development1/14/2025
Enhanc3D Genomics (‘Enhanced’ or ‘the Company’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug discovery.
-
Motivosity Launches Lifestyle Spending Accounts To Help Companies Offer Flexible, Hassle-Free Employee Perks5/27/2025
Motivosity, the leading people-first employee recognition and rewards platform built for today’s workforce, is proud to announce the launch of its new Lifestyle Spending Accounts (LSAs) program.
ABOUT
Catalysts
Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy. For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.
Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.
All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present. When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.
Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst. Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.
Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature. Applications of this technology include oil and petrochemical industries.